Sofimac Innovation

Sofimac Innovation, originally known as iSource, is a French venture capital firm established in 1998 and located in Paris. The firm specializes in early-stage investments, focusing on minority stakes primarily in seed and early-stage companies. Sofimac Innovation has a diverse investment portfolio, targeting sectors such as software, life sciences, engineering sciences, cleantech, and manufacturing across Western Europe. In August 2021, the firm was acquired by UI Investissement, marking a significant transition in its operational structure while continuing its commitment to fostering innovation in various industries.

Philippe Vuagnat Ph.D

Associate Director

Past deals in Southwestern Europe

Vulkam

Series A in 2020
Vulkam SAS is a microtechnology company based in Saint-Martin-d'Hères, France, specializing in the design and production of amorphous metal parts. Founded in 2017, Vulkam focuses on creating biocompatible amorphous metal alloys primarily composed of zirconium, copper, hafnium, nickel, and titanium. The company's innovative products serve various industries, including aerospace, automotive, biomedical, and microcomponents. Vulkam's micromechanical parts are notable for their small size and exceptional strength, offering performance comparable to established industry standards. By leveraging advanced materials science, Vulkam aims to set new benchmarks in metallurgy and metal processing, catering to the growing demand for high-performance, functional components in diverse applications.

Diabeloop

Series B in 2019
Diabeloop is a medical device company based in Grenoble, France, specializing in innovative solutions for diabetes management. Founded in 2015, the company focuses on developing a closed-loop system that automates insulin delivery for individuals with type 1 diabetes. Its AI-based blood sugar monitoring device integrates a sensor that continuously measures glucose levels, a pump that administers insulin, and a smartphone application that connects these components through an embedded algorithm. This technology aims to enhance the treatment experience by reducing the mental burden on patients, allowing them to manage their condition more effortlessly and live their lives with greater freedom.

Igyxos

Series A in 2019
Founded in 2017, Igyxos specializes in developing innovative pharmaceuticals and medical technologies focused on human fertility. The company supports the transfer of potential drug candidates to pre-clinical and clinical phases of development.

Cosmo Tech

Series B in 2018
Cosmo Tech is a global technology company founded in 2010 by Michel Morvan and Hugues de Bantel, based in Lyon, France. Originally known as The CoSMo Company, it specializes in modeling and simulating complex systems across various industries. The company's innovative software transforms raw data into organized knowledge, enabling clients to gain clear insights and run simulations on multiple scenarios to evaluate decision outcomes. This capability supports C-suite executives in making optimal business decisions in complex environments. Over the years, Cosmo Tech has garnered industry recognition, including accolades from Gartner and EY, and has expanded its operations to North America, establishing a presence in San Francisco. With a diverse team of over 70 employees, the company continues to serve clients in both Europe and North America.

eLichens

Venture Round in 2018
eLichens develops air quality solutions that combine low-power micro gas sensors, data collection, and connected stations to analyze, monitor, and predict indoor and outdoor air quality. The company serves industrial, smart city, and consumer markets with a comprehensive solution that spans sensors and services, supported by a portfolio of patents and know-how. It operates offices in Grenoble, France, and Silicon Valley, USA.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.